The Psoriasis Global Market Report 2021-31 by The Business Research Company describes and explains the global psoriasis market and covers 2016 to 2021, termed the historic period, and 2022 to 2026, termed the forecast period, along with further forecasts for the period 2026-2031. The report evaluates the market across each region and for the major economies within each region.
The Psoriasis
Global Market Report 2022 covers psoriasis market drivers, psoriasis market
trends, psoriasis market segments, psoriasis market growth rate, psoriasis market
major players, and psoriasis market size.
View Complete Report:
https://www.thebusinessresearchcompany.com/report/psoriasis-drugs-global-market-report
The psoriasis
market report provides in-depth analysis of the impact of COVID-19 on the global
psoriasis industry along with revised market numbers due to the effects of the
coronavirus and the expected psoriasis market growth numbers for 2022-2031.
The global
psoriasis market size is expected to grow from $17.67 billion in 2021 to $19.98
billion in 2022 at a compound annual growth rate (CAGR) of 13.1%. The growth in
the market is mainly due to the companies rearranging their operations and
recovering from the COVID-19 impact, which had earlier led to restrictive
containment measures involving social distancing, remote working, and the
closure of commercial activities that resulted in operational challenges. The
global psoriasis market share is expected to reach $30.90 billion in 2026 at a
CAGR of 11.5%.
Request Report Sample Now:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2414&type=smp
Psoriasis Global
Market Report 2022 is the most comprehensive report available on this market
and will help gain a truly global perspective as it covers 60 geographies. The
chapter on the impact of COVID-19 gives valuable insights on supply chain
disruptions, logistical challenges, and other economic implications of the
virus on the market. The chapter also covers markets which have been positively
affected by the pandemic.
TBRC’s report
covers the psoriasis market segments-
1) By Drug Class: Interleukin Inhibitors, Corticosteroids, Anti-Inflammatory,
Tumor Necrosis Factor Inhibitor
2) By Distribution Channel: Hospitals, Retail Pharmacies, E-Commerce
3) By Drug Type: Small Molecules, Biologics
4) By Route of Administration: Oral, Tropical, Injectable
5) By Disease Indication: Plaque Psoriasis, Nail Psoriasis, Guttate
Psoriasis, Pustular Psoriasis, Erythrodermic Psoriasis
Table Of Contents
1. Executive Summary
2. Psoriasis Drugs Market Characteristics
3. Psoriasis Drugs Market Trends And Strategies
4. Impact Of COVID-19 On Psoriasis Drugs
5. Psoriasis Drugs Market Size And Growth
.
27. Psoriasis Drugs Market Competitive Landscape And Company Profiles
29. Key Mergers And Acquisitions In The Psoriasis Drugs Market
30. Psoriasis Drugs Market Future Outlook and Potential Analysis
31. Appendix
About The Business Research Company:
The Business
Research Company is a market intelligence firm that excels in company, market,
and consumer research. Located globally it has specialist consultants in a wide
range of industries including manufacturing, healthcare, financial services,
chemicals, and technology. It has offices in the UK, the US and India and
a network of trained researchers in 20+ countries globally.
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Find us on
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany/
Blog: http://blog.tbrc.info/
No comments:
Post a Comment